Literature DB >> 15661235

Immune responses to human papillomavirus in genital tract of women with cervical cancer.

Huan H Nguyen1, Thomas R Broker, Louise T Chow, Ronald D Alvarez, Huong L Vu, Judit Andrasi, Lorie R Brewer, Ge Jin, Jiri Mestecky.   

Abstract

OBJECTIVES: To address a question whether immune responses to HPV infection play a role in control of cervical cancer, we analyzed systemic and mucosal immune responses to HPV in women who underwent radical hysterectomy for cervical cancer (HCC) or loop conization due to cervical dysplasia (LOOP), or had hysterectomy for other reasons (HNN).
METHODS: HPV-specific antibodies in sera and vaginal washes were determined by ELISA using recombinant HPV 16 E7 oncoprotein. Cytokines in vaginal washes were assayed by Linco cytokine multiplex method using Luminex technology. Differential gene expression profiling in cervical tumor was determined by microarray analysis and Real-time RT-PCR.
RESULTS: While levels of HPV-16 E7-specific IgG in vaginal wash were significantly higher in women undergoing HCC and HNN, the levels of the HPV-16 E7-specific IgA in vaginal wash of women with cervical cancer and cervical dysplasia were lower as compared to patients in HNN. Proinflammatory cytokines, such as IL-6 and IL-8, were dominant in vaginal washes of all subjects studied. However, no pattern of Th1-type and Th2-type cytokine induction was observed as demonstrated by protein analysis as well as differential gene expression profiling in cervical tumor.
CONCLUSIONS: These results suggest a selective down-regulation of local HPV-specific IgA responses in women with cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15661235     DOI: 10.1016/j.ygyno.2004.10.019

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  16 in total

1.  Low expression of human histocompatibility soluble leukocyte antigen-G (HLA-G5) in invasive cervical cancer with and without metastasis, associated with papilloma virus (HPV).

Authors:  Marcia C M Guimarães; Christiane P Soares; Eduardo A Donadi; Sophie F M Derchain; Liliana A L A Andrade; Tarsia G A Silva; Marcela K Hassumi; Renata T Simões; Fabiana A Miranda; Régia C P Lira; Janaina Crispim; Edson G Soares
Journal:  J Histochem Cytochem       Date:  2009-09-28       Impact factor: 2.479

2.  Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in high-risk human papillomavirus-related cervical intraepithelial neoplasia.

Authors:  Wen Yang; Yan Song; Yun-Long Lu; Jun-Zhong Sun; Hong-Wei Wang
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

3.  Prognostic significance of the Fas-receptor/Fas-ligand system in cervical squamous cell carcinoma.

Authors:  Enrique Lerma; Marisa Romero; Alberto Gallardo; Cristina Pons; Josefina Muñoz; Josefina Fuentes; Belen Lloveras; Lluis Catasus; Jaime Prat
Journal:  Virchows Arch       Date:  2007-11-14       Impact factor: 4.064

4.  Determination of cytokine protein levels in cervical mucus samples from young women by a multiplex immunoassay method and assessment of correlates.

Authors:  Jay A Lieberman; Anna-Barbara Moscicki; Jan L Sumerel; Yifei Ma; Mark E Scott
Journal:  Clin Vaccine Immunol       Date:  2007-10-31

5.  Identification and characterization of CMP-NeuAc:GalNAc-IgA1 alpha2,6-sialyltransferase in IgA1-producing cells.

Authors:  Milan Raska; Zina Moldoveanu; Hitoshi Suzuki; Rhubell Brown; Rose Kulhavy; Judit Andrasi; Stacy Hall; Huong L Vu; Fredric Carlsson; Gunnar Lindahl; Milan Tomana; Bruce A Julian; Robert J Wyatt; Jiri Mestecky; Jan Novak
Journal:  J Mol Biol       Date:  2007-03-12       Impact factor: 5.469

Review 6.  A Review on Inosine Pranobex Immunotherapy for Cervical HPV-Positive Patients.

Authors:  Stefan Miladinov Kovachev
Journal:  Infect Drug Resist       Date:  2021-06-02       Impact factor: 4.003

Review 7.  The Immune Microenvironment in Human Papilloma Virus-Induced Cervical Lesions-Evidence for Estrogen as an Immunomodulator.

Authors:  Jayshree R S
Journal:  Front Cell Infect Microbiol       Date:  2021-04-30       Impact factor: 5.293

8.  The existence of Th22, pure Th17 and Th1 cells in CIN and Cervical Cancer along with their frequency variation in different stages of cervical cancer.

Authors:  Wenjing Zhang; Xinli Tian; Fidia Mumtahana; Jun Jiao; Teng Zhang; Kimiko Della Croce; Daoxin Ma; Beihua Kong; Baoxia Cui
Journal:  BMC Cancer       Date:  2015-10-16       Impact factor: 4.430

9.  Proteomic alterations in early stage cervical cancer.

Authors:  Coşkun Güzel; Natalia I Govorukhina; G Bea A Wisman; Christoph Stingl; Lennard J M Dekker; Harry G Klip; Harry Hollema; Victor Guryev; Peter L Horvatovich; Ate G J van der Zee; Rainer Bischoff; Theo M Luider
Journal:  Oncotarget       Date:  2018-04-06

10.  Optimising the collection of female genital tract fluid for cytokine analysis in pregnant women.

Authors:  C S Short; R Quinlan; P Bennett; R J Shattock; G P Taylor
Journal:  J Immunol Methods       Date:  2018-04-03       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.